↓ Skip to main content

Cochrane Database of Systematic Reviews

First-line allogeneic hematopoietic stem cell transplantation of HLA-matched sibling donors compared with first-line ciclosporin and/or antithymocyte or antilymphocyte globulin for acquired severe…

Overview of attention for article published in Cochrane database of systematic reviews, July 2013
Altmetric Badge

About this Attention Score

  • Good Attention Score compared to outputs of the same age (68th percentile)
  • Average Attention Score compared to outputs of the same age and source

Mentioned by

twitter
1 tweeter
wikipedia
3 Wikipedia pages

Citations

dimensions_citation
18 Dimensions

Readers on

mendeley
190 Mendeley
Title
First-line allogeneic hematopoietic stem cell transplantation of HLA-matched sibling donors compared with first-line ciclosporin and/or antithymocyte or antilymphocyte globulin for acquired severe aplastic anemia
Published in
Cochrane database of systematic reviews, July 2013
DOI 10.1002/14651858.cd006407.pub2
Pubmed ID
Authors

Frank Peinemann, Carmen Bartel, Ulrich Grouven

Abstract

Acquired severe aplastic anemia is a rare and potentially fatal disease, which is characterized by hypocellular bone marrow and pancytopenia. The major signs and symptoms are severe infections, bleeding, and exhaustion. First-line allogeneic hematopoietic stem cell transplantation (HSCT) of a human leukocyte antigen (HLA)-matched sibling donor (MSD) is a treatment for newly diagnosed patients with severe aplastic anemia. First-line treatment with ciclosporin and/or antithymocyte or antilymphocyte globulin (as first-line immunosuppressive therapy) is an alternative to MSD-HSCT and is indicated for patients where no MSD is found.

Twitter Demographics

The data shown below were collected from the profile of 1 tweeter who shared this research output. Click here to find out more about how the information was compiled.

Mendeley readers

The data shown below were compiled from readership statistics for 190 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Colombia 2 1%
Netherlands 1 <1%
South Africa 1 <1%
Canada 1 <1%
Unknown 185 97%

Demographic breakdown

Readers by professional status Count As %
Student > Master 34 18%
Student > Bachelor 29 15%
Researcher 16 8%
Student > Postgraduate 16 8%
Student > Ph. D. Student 15 8%
Other 35 18%
Unknown 45 24%
Readers by discipline Count As %
Medicine and Dentistry 90 47%
Nursing and Health Professions 13 7%
Psychology 8 4%
Biochemistry, Genetics and Molecular Biology 5 3%
Pharmacology, Toxicology and Pharmaceutical Science 5 3%
Other 25 13%
Unknown 44 23%

Attention Score in Context

This research output has an Altmetric Attention Score of 4. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 17 October 2019.
All research outputs
#6,457,435
of 21,347,688 outputs
Outputs from Cochrane database of systematic reviews
#8,312
of 12,073 outputs
Outputs of similar age
#52,917
of 176,835 outputs
Outputs of similar age from Cochrane database of systematic reviews
#74
of 119 outputs
Altmetric has tracked 21,347,688 research outputs across all sources so far. This one has received more attention than most of these and is in the 69th percentile.
So far Altmetric has tracked 12,073 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 29.0. This one is in the 29th percentile – i.e., 29% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 176,835 tracked outputs that were published within six weeks on either side of this one in any source. This one has gotten more attention than average, scoring higher than 68% of its contemporaries.
We're also able to compare this research output to 119 others from the same source and published within six weeks on either side of this one. This one is in the 36th percentile – i.e., 36% of its contemporaries scored the same or lower than it.